Literature DB >> 30033314

Polymeric chitosan-glycolipid nanocarriers for an effective delivery of marine carotenoid fucoxanthin for induction of apoptosis in human colon cancer cells (Caco-2 cells).

Hindupur Ravi1, Nawneet Kurrey1, Yuki Manabe2, Tatsuya Sugawara2, Vallikannan Baskaran3.   

Abstract

Fucoxanthin (FUCO), a marine carotenoid is photo-, and thermo-labile and poorly bioavailable due to its lipophilicity. Hence, we developed a chitosan (CS) + glycolipid (GL) nanogels (NGs) to increase cellular uptake and anticancer efficacy of FUCO (10 μM) in human colon cells (Caco-2). Effect of FUCO loaded in NGs with/with no GL was studied in comparison with micellar FUCO. Results showed that the cell viability was lower (p < 0.05) in NGs + GL (50.5%) compared to NGs (-GL) (66.5%) and the mixed micelles (72.5%) groups over 48 h exposure. An enhanced reactive oxygen species (ROS) generation was evident in NGs + GL (379.2%) group compared to NGs (-GL) and mixed micelles groups. Further, induction of apoptosis with an increased chromatin condensation and DNA fragmentation as evidenced in DAPI staining and DNA ladder assay were higher in NGs + GL group than other groups. Down-regulation of Bcl-2 (6.6 folds) was higher in NGs + GL group compared to NGs (-GL) (1.94 fold) and mixed micelles (1.19 fold) groups. Higher Bax up-regulation in NGs + GL compared to other groups supports the Bcl-2 down regulation. Mitochondrial membrane polarisation (ΔΨm) was higher in NGs + GL group (2.46 fold) compared to NGs (-GL) (1.91 fold) and mixed micelles (1.26 fold) groups. The cellular FUCO uptake illustrated a positive correlation between its level (pmol/106 cells) in NGs + GL (758.3) and enhanced caspase-3 activity (25.8 folds). This could be the reason for an increased apoptotic activity in NGs + GL group than other groups. Results demonstrate that delivery of FUCO in NGs + GL carrier aids cellular uptake and chemotherapeutic potential of FUCO. Results further demonstrate, for the first time, higher anti-cancer activity of FUCO loaded in NGs + GL and the effect was through ROS generation via a caspase dependent mechanism in Caco-2 cells.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Apoptosis; Caco-2; Chitosan; Fucoxanthin; Glycolipid; Nanocarrier

Mesh:

Substances:

Year:  2018        PMID: 30033314     DOI: 10.1016/j.msec.2018.06.018

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  6 in total

1.  Brown algae and barley-based anti-obesity food and its safety in C57BL6 mice.

Authors:  Priya Prakash Sharma; V Vanajakshi; Devendra Haware; Vallikannan Baskaran
Journal:  J Food Sci Technol       Date:  2022-06-15       Impact factor: 3.117

Review 2.  Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress.

Authors:  Raúl Ortíz; Francisco Quiñonero; Beatriz García-Pinel; Marco Fuel; Cristina Mesas; Laura Cabeza; Consolación Melguizo; Jose Prados
Journal:  Cancers (Basel)       Date:  2021-04-24       Impact factor: 6.639

Review 3.  Oxidative Stress and Marine Carotenoids: Application by Using Nanoformulations.

Authors:  Yasin Genç; Hilal Bardakci; Çiğdem Yücel; Gökçe Şeker Karatoprak; Esra Küpeli Akkol; Timur Hakan Barak; Eduardo Sobarzo-Sánchez
Journal:  Mar Drugs       Date:  2020-08-13       Impact factor: 5.118

Review 4.  Anti-Inflammatory and Anticancer Effects of Microalgal Carotenoids.

Authors:  Javier Ávila-Román; Sara García-Gil; Azahara Rodríguez-Luna; Virginia Motilva; Elena Talero
Journal:  Mar Drugs       Date:  2021-09-23       Impact factor: 5.118

Review 5.  The Critical Studies of Fucoxanthin Research Trends from 1928 to June 2021: A Bibliometric Review.

Authors:  Yam Sim Khaw; Fatimah Md Yusoff; Hui Teng Tan; Nur Amirah Izyan Noor Mazli; Muhammad Farhan Nazarudin; Noor Azmi Shaharuddin; Abdul Rahman Omar
Journal:  Mar Drugs       Date:  2021-10-26       Impact factor: 5.118

Review 6.  Seaweed Secondary Metabolites In Vitro and In Vivo Anticancer Activity.

Authors:  Djenisa H A Rocha; Ana M L Seca; Diana C G A Pinto
Journal:  Mar Drugs       Date:  2018-10-26       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.